Alexandra Kropotova's most recent trade in SAB Biotherapeutics Inc was a trade of 9,072 Common Stock done . Disclosure was reported to the exchange on Dec. 18, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
SAB Biotherapeutics Inc | Alexandra Kropotova | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 18 Dec 2024 | 9,072 | 48,428 | - | - | Common Stock | |
SAB Biotherapeutics Inc | Alexandra Kropotova | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 140,000 | 140,000 | - | - | Employee Stock Option (right to buy) |